These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10969818)

  • 1. p53 promotes selection for Fas-mediated apoptotic resistance.
    Maecker HL; Koumenis C; Giaccia AJ
    Cancer Res; 2000 Aug; 60(16):4638-44. PubMed ID: 10969818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival.
    Hohlbaum AM; Moe S; Marshak-Rothstein A
    J Exp Med; 2000 Apr; 191(7):1209-20. PubMed ID: 10748238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human melanoma cells do not express Fas (Apo-1/CD95) ligand.
    Chappell DB; Zaks TZ; Rosenberg SA; Restifo NP
    Cancer Res; 1999 Jan; 59(1):59-62. PubMed ID: 9892185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.
    Müller M; Wilder S; Bannasch D; Israeli D; Lehlbach K; Li-Weber M; Friedman SL; Galle PR; Stremmel W; Oren M; Krammer PH
    J Exp Med; 1998 Dec; 188(11):2033-45. PubMed ID: 9841917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient.
    Real LM; Jimenez P; Kirkin A; Serrano A; García A; Cantón J; Zeuthen J; Garrido F; Ruiz-Cabello F
    Cancer Immunol Immunother; 2001 Jan; 49(11):621-8. PubMed ID: 11225993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Cellular Metabolism and Hypoxia by p53.
    Humpton TJ; Vousden KH
    Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27371670
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kaller M; Forné I; Imhof A; Hermeking H
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting p53 pathways: mechanisms, structures, and advances in therapy.
    Wang H; Guo M; Wei H; Chen Y
    Signal Transduct Target Ther; 2023 Mar; 8(1):92. PubMed ID: 36859359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis.
    Sulejmani O; Grunewald L; Andersch L; Schwiebert S; Klaus A; Winkler A; Astrahantseff K; Eggert A; Henssen AG; Schulte JH; Anders K; Künkele A
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome.
    Brandetti E; Focaccetti C; Pezzolo A; Ognibene M; Folgiero V; Cotugno N; Benvenuto M; Palma P; Manzari V; Rossi P; Fruci D; Bei R; Cifaldi L
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.
    Lu C; Klement JD; Yang D; Albers T; Lebedyeva IO; Waller JL; Liu K
    Cancer Lett; 2020 Apr; 476():87-96. PubMed ID: 32061753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XZ-1 regulates cell apoptosis of gastric epithelial dysplasia via NF-κB/p53/Ki67 signaling pathway.
    Xu B; Zhang AM; Li F; Cui M; Han J; Cao Q
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29588340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yet another function of p53--the switch that determines whether radiation-induced autophagy will be cytoprotective or nonprotective: implications for autophagy inhibition as a therapeutic strategy.
    Chakradeo S; Sharma K; Alhaddad A; Bakhshwin D; Le N; Harada H; Nakajima W; Yeudall WA; Torti SV; Torti FM; Gewirtz DA
    Mol Pharmacol; 2015 May; 87(5):803-14. PubMed ID: 25667224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089.
    Sharma K; Goehe RW; Di X; Hicks MA; Torti SV; Torti FM; Harada H; Gewirtz DA
    Autophagy; 2014; 10(12):2346-61. PubMed ID: 25629933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines.
    Izetti P; Hautefeuille A; Abujamra AL; de Farias CB; Giacomazzi J; Alemar B; Lenz G; Roesler R; Schwartsmann G; Osvaldt AB; Hainaut P; Ashton-Prolla P
    Invest New Drugs; 2014 Oct; 32(5):783-94. PubMed ID: 24838627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD95 is part of a let-7/p53/miR-34 regulatory network.
    Hau A; Ceppi P; Peter ME
    PLoS One; 2012; 7(11):e49636. PubMed ID: 23166734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma.
    Roh JL; Kang SK; Minn I; Califano JA; Sidransky D; Koch WM
    Oral Oncol; 2011 Jan; 47(1):8-15. PubMed ID: 21109480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phyllanthus spp. induces selective growth inhibition of PC-3 and MeWo human cancer cells through modulation of cell cycle and induction of apoptosis.
    Tang YQ; Jaganath IB; Sekaran SD
    PLoS One; 2010 Sep; 5(9):e12644. PubMed ID: 20838625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis.
    Selvakumaran M; Yao KS; Feldman MD; O'Dwyer PJ
    Biochem Pharmacol; 2008 Feb; 75(3):627-38. PubMed ID: 18178171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers.
    Mijatovic T; Mathieu V; Gaussin JF; De Nève N; Ribaucour F; Van Quaquebeke E; Dumont P; Darro F; Kiss R
    Neoplasia; 2006 May; 8(5):402-12. PubMed ID: 16790089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.